AlphaFold for Drug Discovery

AlphaFold for Drug Discovery stands as one of the most impactful AI applications in healthcare, with Google DeepMind's protein structure database expanding to over 200 million predicted protein structures by 2023 and updating to predict molecular interactions in 2024. This tool has become foundational for pharmaceutical R&D, integrated by major companies including Pfizer, Novartis, and AstraZeneca into their drug discovery pipelines. Researchers credit AlphaFold with speeding up structural biology work that once took years using traditional crystallography.